Small cell transformation in crizotinib‐resistant ROS1‐rearranged non‐small cell lung cancer with retention of ROS1 fusion: A case report

QR Code

Small cell transformation in crizotinib‐resistant ROS1‐rearranged non‐small cell lung cancer with retention of ROS1 fusion: A case report

Abstract C‐ros oncogene 1 receptor tyrosine kinase (ROS1) rearrangement has been detected in patients with advanced non‐small cell lung cancer (NSCLC). Although ROS1 tyrosine kinase inhibitors (TKIs) provide a survival benefit for patients with ROS1‐rearranged advanced NSCLC, subsequent therapy rema...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Chi‐Hao Wu, Po‐Lan Su, Che‐Wei Hsu, Chang‐Yao Chu, Chien‐Chung Lin
Format:	article
Langue:	EN
Publié:	Wiley 2021
Sujets:	adenocarcinoma ROS1 rearrangement small cell transformation Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/ed32ab372512427db583dba7cab3a7cf
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives
par: Rossi G, et autres
Publié: (2017)

Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients
par: Mehta A, et autres
Publié: (2020)

Rapidly Destructive Coxarthrosis as a Potential Side Effect of Crizotinib in a Patient with ROS1-Positive Lung Adenocarcinoma
par: Takamori S, et autres
Publié: (2020)

Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives
par: Giroux Leprieur E, et autres
Publié: (2016)

TKI-addicted ROS1-rearranged cells are destined to survival or death by the intensity of ROS1 kinase activity
par: Hayato Ogura, et autres
Publié: (2017)

ROS-induced dramatic lipid changes in Arabidopsis
par: Tianlin Jin, et autres
Publié: (2021)

Targeting RET-rearranged non-small-cell lung cancer: future prospects
par: Bronte G, et autres
Publié: (2019)

Spotlight on brigatinib and its potential in the treatment of patients with metastatic ALK-positive non-small cell lung cancer who are resistant or intolerant to crizotinib
par: Jain RK, et autres
Publié: (2017)

Astilbin reduces ROS accumulation and VEGF expression through Nrf2 in psoriasis-like skin disease
par: Wang,Wuyuntana, et autres
Publié: (2019)

ROS-Based Nanoparticles for Atherosclerosis Treatment
par: Xin Hu, et autres
Publié: (2021)

The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models
par: Ryohei Katayama, et autres
Publié: (2019)

Elemene Nanoemulsion Inhibits Metastasis of Breast Cancer by ROS Scavenging
par: Han B, et autres
Publié: (2021)

Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date
par: Facchinetti F, et autres
Publié: (2019)

Punicalin Ameliorates Cell Pyroptosis Induced by LPS/ATP Through Suppression of ROS/NLRP3 Pathway
par: Shen R, et autres
Publié: (2021)

Jaime Ros Bosch, economista*
par: José I. Casar
Publié: (2019)

NOX4-derived ROS-induced overexpression of FOXM1 regulates aerobic glycolysis in glioblastoma
par: Xiangsheng Su, et autres
Publié: (2021)

Amide-Assisted Rearrangement of Hydroxyarylformimidoyl Chloride to Diarylurea
par: Xizhong Song, et autres
Publié: (2021)

Regulation of ROS-Dependent JNK Pathway by 2’-Hydroxycinnamaldehyde Inducing Apoptosis in Human Promyelocytic HL-60 Leukemia Cells
par: Kyung-Sook Chung, et autres
Publié: (2021)

Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy
par: Pandya AD, et autres
Publié: (2019)

Enterovirus 71 induces neural cell apoptosis and autophagy through promoting ACOX1 downregulation and ROS generation
par: Lei You, et autres
Publié: (2020)

Impacts of exogenous ROS scavenger ascorbic acid on the storability and quality attributes of fresh longan fruit
par: Jingyun Liu, et autres
Publié: (2021)

ROS Metabolism Perturbation as an Element of Mode of Action of Allelochemicals
par: Pawel Staszek, et autres
Publié: (2021)

Hollow CeO2 with ROS-Scavenging Activity to Alleviate Colitis in Mice
par: Yang J, et autres
Publié: (2021)

Xp11.2 Translocation Renal Cell Carcinoma With TFE3 Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners
par: Yan Ge, et autres
Publié: (2021)

Reactive oxygen species (ROS)-responsive nanoprobe for bioimaging and targeting therapy of osteoarthritis
par: Chong Shen, et autres
Publié: (2021)

Condensed tannin reactivity inhibition by internal rearrangements: Detection by CP-MAS 13C NMR
par: Navarrete,P, et autres
Publié: (2011)

ROS middle-layer integration into Unity3D as an interface option for propulsion drive simulations of autonomous vehicles
par: Sergei Jegorov, et autres
Publié: (2021)

Induction of ROS and DNA damage-dependent senescence by icaritin contributes to its antitumor activity in hepatocellular carcinoma cells
par: Shikang Wang, et autres
Publié: (2019)

Scutellarin-induced A549 cell apoptosis depends on activation of the transforming growth factor-β1/smad2/ROS/caspase-3 pathway
par: Zhang Guang-Yan, et autres
Publié: (2021)

ROS play an important role in ATPR inducing differentiation and inhibiting proliferation of leukemia cells by regulating the PTEN/PI3K/AKT signaling pathway
par: Feng,Yubin, et autres
Publié: (2019)

Peiminine Induces G0/G1-Phase Arrest, Apoptosis, and Autophagy via the ROS/JNK Signaling Pathway in Human Osteosarcoma Cells in Vitro and in Vivo
par: Lei Yu, et autres
Publié: (2021)

ROS-Nrf2 pathway mediates the development of TGF-β1-induced epithelial-mesenchymal transition through the activation of Notch signaling
par: Kai Yazaki, et autres
Publié: (2021)

Group A Streptococcus Induces LAPosomes via SLO/β1 Integrin/NOX2/ROS Pathway in Endothelial Cells That Are Ineffective in Bacterial Killing and Suppress Xenophagy
par: Yi-Lin Cheng, et autres
Publié: (2019)

Crizotinib-induced immunogenic cell death in non-small cell lung cancer
par: Peng Liu, et autres
Publié: (2019)

The Antileukemic Effect of Xestoquinone, A Marine-Derived Polycyclic Quinone-Type Metabolite, Is Mediated through ROS-Induced Inhibition of HSP-90
par: Kuan-Chih Wang, et autres
Publié: (2021)

Epithelial Aryl Hydrocarbon Receptor Protects From Mucus Production by Inhibiting ROS-Triggered NLRP3 Inflammasome in Asthma
par: Xinyue Hu, et autres
Publié: (2021)

Clinical use of crizotinib for the treatment of non-small cell lung cancer
par: Roberts PJ
Publié: (2013)

ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication
par: Bingfeng Liang, et autres
Publié: (2021)

Clinical Significance of Serum PGC-1 Alpha Levels in Diabetes Mellitus with Myocardial Infarction Patients and Reduced ROS-Oxidative Stress in Diabetes Mellitus with Myocardial Infarction Model
par: Zhu N, et autres
Publié: (2020)

Smart Design of Mitochondria-Targeted and ROS-Responsive CPI-613 Delivery Nanoplatform for Bioenergetic Pancreatic Cancer Therapy
par: Yi-Mei Zhang, et autres
Publié: (2021)